Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Anemia, Refractory, with Excess of Blasts × Drug Therapy × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 18 Neoplasm Metastasis 8 Lung Neoplasms 7 Colorectal Neoplasms 7 Breast Neoplasms 7 Esophageal Squamous Cell Carcinoma 6 Stomach Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Small Cell Lung Carcinoma 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4 Rectal Neoplasms 4 Leukemia, Myeloid, Acute 4 Head and Neck Neoplasms 4 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Fallopian Tube Neoplasms 3 Esophageal Neoplasms 3 Urinary Bladder Neoplasms 2 Sarcoma 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Oropharyngeal Neoplasms 2 Neoplasms 2 Nasopharyngeal Carcinoma 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia 2 Gastrointestinal Neoplasms 2 Colonic Neoplasms 2 Cholangiocarcinoma 2

Interventions

Cyclophosphamide 6 fludarabine 5 Mycophenolic Acid 5 Azacitidine 5 Whole-Body Irradiation 4 Tacrolimus 4 venetoclax 3 fludarabine phosphate 3 decitabine and cedazuridine drug combination 2 Vorinostat 2 Specimen Handling 2 Melphalan 2 Granulocyte Colony-Stimulating Factor 2 Busulfan 2 Biopsy 2 sulforaphane 1 ruxolitinib 1 enasidenib 1 cedazuridine 1 Triamcinolone 1 TAK-243 1 Stem Cell Transplantation 1 Sirolimus 1 Peripheral Blood Stem Cell Transplantation 1 Mesna 1 Lenalidomide 1 Hematopoietic Stem Cell Transplantation 1 Filgrastim 1 Cyclosporins 1 Cyclosporine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡